EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy and safety of topical cyclosporine 0.1% eye drops in the treatment of dry eye disease in patients with rheumatoid arthritis

Norhan T.M. Rizk, Amr I. Sharawy, Rehab M.R. Gabal, Ehab M.E. Saad

Journal of the Egyptian Ophthalmological Society · 2026-07 · 119 (3) · 341-349

DOI: 10.4103/ejos.ejos_107_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Egyptian Ophthalmological Society, online erschienen am 09.07.2026. Verfasst von Norhan T.M. Rizk und 3 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The most prevalent ocular symptom of rheumatoid arthritis (RA) is dry eye disease (DED), especially keratoconjunctivitis sicca, which has a major negative impact on patients’ quality of life. Immunomodulatory drugs such as topical cyclosporine A (CsA) target the chronic inflammation that is a part of DED etiology.

Aims

To evaluate the efficacy of 0.1% CsA eye drops in conjunction with artificial tear eye drops for the treatment of DED in RA patients. Patients and methods A total of 60 RA patients who met the ACR-EULAR 2010 criteria were included in this prospective, randomized, controlled, interventional clinical study. For a month, patients were randomly assigned to either the Study group (topical CsA 0.1%+artificial tears, n =30) or the Control group (artificial tears alone, n =30).

Results

At 1 month, all primary endpoints showed substantially better results for the Study group than for the Control group ( P

Zitieren

APA

Rizk, N. T., Sharawy, A. I., Gabal, R. M., & Saad, E. M. (2026). Efficacy and safety of topical cyclosporine 0.1% eye drops in the treatment of dry eye disease in patients with rheumatoid arthritis. Journal of the Egyptian Ophthalmological Society, 119(3), 341-349. https://doi.org/10.4103/ejos.ejos_107_25

Vancouver

Rizk NT, Sharawy AI, Gabal RM, Saad EM. Efficacy and safety of topical cyclosporine 0.1% eye drops in the treatment of dry eye disease in patients with rheumatoid arthritis. Journal of the Egyptian Ophthalmological Society. 2026;119(3):341-349. doi:10.4103/ejos.ejos_107_25

BibTeX
@article{Rizk2026,
  author = {Rizk, Norhan T.M. and Sharawy, Amr I. and Gabal, Rehab M.R. and Saad, Ehab M.E.},
  title = {Efficacy and safety of topical cyclosporine 0.1% eye drops in the treatment of dry eye disease in patients with rheumatoid arthritis},
  journal = {Journal of the Egyptian Ophthalmological Society},
  year = {2026},
  volume = {119},
  number = {3},
  pages = {341--349},
  doi = {10.4103/ejos.ejos_107_25}
}
Kostenlos starten →